跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lucrin Depot Paediatric leuprorelin acetate 30 mg powder for injection prefilled dual chamber syringe - TGA Drug Approval Details
Approvals
/
TGA
/
Lucrin Depot Paediatric leuprorelin acetate 30 mg powder for injection prefilled dual chamber syringe
Approved
STANDARD
Lucrin Depot Paediatric leuprorelin acetate 30 mg powder for injection prefilled dual chamber syringe
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
476a04217f57859b
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
476a04217f57859b
Product Name
Lucrin Depot Paediatric leuprorelin acetate 30 mg powder for injection prefilled dual chamber syringe
Artg Id
218936
Artg Name
Lucrin Depot Paediatric leuprorelin acetate 30 mg powder for injection prefilled dual chamber syringe
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2014-10-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/47044a1de38a3dd13364c28407808903.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3766ff8e54dfddcfe5ce365786759c31.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
476a04217f57859b
Type
Standard
Back to TGA Approvals